Meridian Bioscience falls after swinging to loss in Q3

VivoPower

05/08/2022 14:02

** Shares of diagnostic products maker Meridian Bioscience
 VIVO.O  down ~2% at $31.08 in light premarket vols
    ** Co swings to a loss in Q3, reports 16 cents/shr loss vs
26 cents/shr profit a year earlier  urn:newsml:reuters.com:*:nPn980wBXa
    ** Revenue from life sciences segment plunged 22% from last
year, when strong demand for COVID-19 testing helped the unit -
VIVO
    ** Excluding items, costs jumped 13% in the quarter
    ** As of last close, VIVO stock had jumped 55% YTD

 (Reporting by Niket Nishant in Bengaluru)
 ((Niket.Nishant@thomsonreuters.com;))